meganero.blogg.se

• #RASA SURABHI TRIAL#

#RASA SURABHI TRIAL#

Here, we describe a trial designed to determine the impact of age-based targeting of biannual azithromycin on mortality and antimicrobial resistance.ĪVENIR is a cluster-randomized, placebo-controlled, double-masked, response-adaptive large simple trial in Niger. The World Health Organization has proposed targeting this intervention to the subgroup of children 1-11 months old to reduce selection for antimicrobial resistance. distribution of azithromycin to children 1-59 months old reduced mortality by 14% in a cluster-randomized trial.

11 Institute for Global Health Sciences, University of California, San Francisco, USA. 10 Department of Epidemiology and Biostatistics, University of California, San Francisco, USA. 9 Department of Ophthalmology, University of California, 490 Illinois Street, San Francisco, CA, 94158, USA.

Proctor Foundation, University of California, San Francisco, USA. 7 Institute for Global Health Sciences, University of California, San Francisco, USA.6 Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.5 Department of Ophthalmology, University of California, 490 Illinois Street, San Francisco, CA, 94158, USA.